Evidence map›Paper›PMID 33449250›Full record

ArticlePharmaceutical research2021

Evaluation of Intranasal Vaccine Delivery Using Anatomical Replicas of Infant Nasal Airways.

John V Wilkins, Laleh Golshahi, Nausheen Rahman, Lillian Li

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

John V WilkinsDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University, 800 E. Leigh St, Richmond, Virginia, 23298, USA.
Laleh GolshahiDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University, 800 E. Leigh St, Richmond, Virginia, 23298, USA. lgolshahi@vcu.edu.ORCID http://orcid.org/0000-0003-3450-7160
Nausheen RahmanBioprocess Research and Development, Sanofi Pasteur Ltd., Building 95, 1755 Steeles Avenue West, Toronto, Ontario, M2R 3T4, Canada.
Lillian LiBioprocess Research and Development, Sanofi Pasteur Ltd., Building 95, 1755 Steeles Avenue West, Toronto, Ontario, M2R 3T4, Canada. lillian.li@Sanofi.com.
Sanofi (Canada) · CAVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNasal delivery is a favorable route for vaccination against most respiratory infections, as antigen deposited in the nasal turbinate and Waldeyer's ring areas induce mucosal and systemic immune responses. However, little is known about the nasal distribution of the vaccines, specifically for infants.

methodsAnatomical nasal replicas of five subjects, 3-24 months, were developed to assess local intranasal vaccine delivery using MAD Nasal™ device, and understand impact of breathing conditions and administration parameters. High performance liquid chromatography was used to quantify the deposition pattern and determine the delivery efficiency.

resultsThe delivery efficiency on average for all models was found to be 86.57±14.23%. There were no significant differences in the total delivery efficiency between the models in all cases. However, the regional deposition pattern was altered based on the model and subsequent administration. Furthermore, removing the foam tip from the MAD Nasal™ device, to study the impact of insertion length, did not significantly increase the efficiency within the two models tested, 5- and 16-month.

conclusionIncorporating nasal replicas in testing provided a benchmark to determine the efficiency of a common intranasal vaccine delivery combination product. This proposed platform would allow comparing other potential nasal vaccine delivery devices.

Indexed as

Models, AnatomicAdministration, IntranasalChild, PreschoolDrug Evaluation, PreclinicalHumansInfantNasal MucosaNosePrinting, Three-DimensionalTomography, X-Ray ComputedVaccinationVaccinesVaccinesdose depositioninfantintranasal vaccinesin vitronasal models

Identifiers

PMID33449250
OpenAlexW3120737753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.